Impact of glioma metabolism-related gene ALPK1 on tumor immune heterogeneity and the regulation of the TGF-β pathway
BackgroundRecent years have seen persistently poor prognoses for glioma patients. Therefore, exploring the molecular subtyping of gliomas, identifying novel prognostic biomarkers, and understanding the characteristics of their immune microenvironments are crucial for improving treatment strategies a...
Saved in:
Main Authors: | YaoFeng Hu, Sen Qin, RuCui Deng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1512491/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive analysis reveals cholesterol metabolism-related signature for predicting prognosis and guiding individualized treatment of glioma
by: Dengfeng Lu, et al.
Published: (2025-01-01) -
Bulk and single-cell transcriptome revealed the metabolic heterogeneity in human glioma
by: Yong Xiao, et al.
Published: (2025-01-01) -
V-ATPase in glioma stem cells: a novel metabolic vulnerability
by: Alessandra Maria Storaci, et al.
Published: (2025-01-01) -
Fusobacterium nucleatum upregulates the immune inhibitory receptor PD-L1 in colorectal cancer cells via the activation of ALPK1
by: Coco Duizer, et al.
Published: (2025-12-01) -
RBM47 is a novel immunotherapeutic target and prognostic biomarker in gliomas
by: Wei Wei, et al.
Published: (2025-01-01)